Medical Advisor - Mental Health (Schizophrenia).
ROVI GmbH is the German affiliate of Laboratorios Farmacéuticos ROVI, S.A. (www.ROVI.es) a public global Spanish pharmaceutical company, whose activities comprise the development, manufacture and marketing of pharmaceutical products.
ROVI is a public limited company with revenues of circa. Eur 381 mill. The company is in a continuous international expansion process, has subsidiaries in Germany, Portugal, the United Kingdom, Italy, France and Poland, and has a diversified marketing portfolio of more than 40 products in more than 100 countries.
ROVI’s portfolio of products in the research and development phase is numerous. The most significant R&D milestones in recent years relate, firstly, the development of heparin-based products (with the launch of enoxaparin biosimilar in Germany 2017) and secondly, the development of new controlled drug release systems, based on the patented ISM® (in-situ microparticles) technology.
The first product development using this technology, is Risperidone ISM® (registered with the trademark Doria®). Doria® is a monthly Long Acting Injectable (LAI) of risperidone addressed for the treatment of schizophrenia.
ROVI is looking for a highly motivated, hard-working, and customer focused individual to be part of a new team of specialists who will be responsible for Doria® in Germany. This exciting position is essential for the future growth of the company.
Main purpose of the role
An opportunity for a Medical Advisor to join a solid and rapidly growing company in Germany.
The role would be ideal for an ambitious individual with a medical background, as well as somebody who can combine this with a knowledge of antipsychotics.
The role would allow a close involvement with KOLs and key decision-makers within the schizophrenia field. The candidate will be responsible to drive the brand performance by displaying deep understanding of the market context and of the different stakeholde...